Citi Discount Zert AMGN 21.06.202.../ DE000KF6CE90 /
| 6/28/2022 8:06:34 AM | Chg.+0.01 | Bid8:50:57 PM | Ask8:50:57 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 157.34EUR | +0.01% | 158.04 Bid Size: 2,000 |
158.09 Ask Size: 2,000 |
Amgen | - USD | 6/21/2023 | Call |
GlobeNewswire
3/23
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire
3/23
OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...
GlobeNewswire
3/21
Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neu...
GlobeNewswire
3/21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/17
CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire
3/15
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
GlobeNewswire
3/14
OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico
GlobeNewswire
3/9
Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors
GlobeNewswire
3/7
Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board
GlobeNewswire
3/3
Entera Bio to Report Business and Financial Results for the Year Ended December 31, 2021 on March 8,...
GlobeNewswire
3/2
AmMax Bio Announces Positive Phase 2 Results Demonstrating Proof-of-Concept for the Novel Local Deli...
GlobeNewswire
3/1
CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...
GlobeNewswire
3/1
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commerci...
GlobeNewswire
2/28
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corpor...